Q8BLG0
Gene name |
Phf20 (Hca58) |
Protein name |
PHD finger protein 20 |
Names |
Hepatocellular carcinoma-associated antigen 58 homolog |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:228829 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q8BLG0
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q8BLG0-F1 | Predicted | AlphaFoldDB |
61 variants for Q8BLG0
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs3388596642 | 57 | W>R | No | EVA | |
| rs3392136458 | 90 | N>D | No | EVA | |
| rs3392419685 | 92 | Q>ASTCWFI* | No | EVA | |
| rs3392419685 | 93 | V>E | No | EVA | |
| rs3392471473 | 93 | V>E | No | EVA | |
| rs3392503671 | 95 | A>T | No | EVA | |
| rs3388596697 | 117 | T>I | No | EVA | |
| rs3388604594 | 173 | T>M | No | EVA | |
| rs586039672 | 179 | D>E | No | EVA | |
| rs1134791568 | 190 | R>Q | No | EVA | |
| rs1132558190 | 205 | K>N | No | EVA | |
| rs1133060557 | 228 | E>K | No | EVA | |
| rs242923733 | 247 | K>R | No | EVA | |
| rs13476860 | 248 | N>S | No | EVA | |
| rs3388600041 | 255 | E>K | No | EVA | |
| rs1134731583 | 263 | P>L | No | EVA | |
| rs3392368336 | 268 | P>S | No | EVA | |
| rs3388600049 | 298 | L>I | No | EVA | |
| rs3388590479 | 304 | D>H | No | EVA | |
| rs3388607197 | 318 | N>Y | No | EVA | |
| rs3388604721 | 333 | T>A | No | EVA | |
| rs239476987 | 344 | S>L | No | EVA | |
| rs3388605515 | 361 | K>R | No | EVA | |
| rs228544768 | 384 | S>C | No | EVA | |
| rs252205561 | 388 | C>G | No | EVA | |
| rs585641157 | 389 | H>P | No | EVA | |
| rs581889813 | 399 | D>A | No | EVA | |
| rs3388602571 | 446 | V>M | No | EVA | |
| rs3412824812 | 474 | Y>F | No | EVA | |
| rs3388597316 | 535 | K>N | No | EVA | |
| rs3388606985 | 565 | S>R | No | EVA | |
| rs3388607491 | 593 | S>R | No | EVA | |
| rs3392338532 | 600 | D>N | No | EVA | |
| rs218151613 | 652 | D>N | No | EVA | |
| rs3392430924 | 676 | Q>P | No | EVA | |
| rs3392280619 | 678 | W>C | No | EVA | |
| rs3392338537 | 681 | G>W | No | EVA | |
| rs3392457551 | 682 | V>D | No | EVA | |
| rs3392280623 | 682 | V>L | No | EVA | |
| rs3388607477 | 691 | V>M | No | EVA | |
| rs3388597282 | 708 | P>H | No | EVA | |
| rs3388590525 | 708 | P>S | No | EVA | |
| rs263010890 | 731 | D>E | No | EVA | |
| rs3388608311 | 737 | Q>K | No | EVA | |
| rs3392338451 | 739 | A>TIFLAFWWE* | No | EVA | |
| rs3388597257 | 751 | D>G | No | EVA | |
| rs3388606742 | 763 | Q>H | No | EVA | |
| rs3388606175 | 787 | H>R | No | EVA | |
| rs3388590547 | 790 | E>K | No | EVA | |
| rs1133272615 | 794 | H>Y | No | EVA | |
| rs583748471 | 803 | A>T | No | EVA | |
| rs237772575 | 817 | A>T | No | EVA | |
| rs3392503632 | 818 | V>M | No | EVA | |
| rs3392448631 | 822 | S>P | No | EVA | |
| rs3388598191 | 824 | L>P | No | EVA | |
| rs3388607241 | 826 | R>L | No | EVA | |
| rs3388604667 | 828 | V>A | No | EVA | |
| rs3388602117 | 836 | E>G | No | EVA | |
| rs3388598151 | 903 | V>G | No | EVA | |
| rs3392368335 | 950 | E>V* | No | EVA | |
| rs3388606681 | 989 | H>R | No | EVA |
No associated diseases with Q8BLG0
7 regional properties for Q8BLG0
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | Zinc finger, PHD-type | 657 - 701 | IPR001965 |
| domain | Tudor domain | 11 - 71 | IPR002999-1 |
| domain | Tudor domain | 85 - 141 | IPR002999-2 |
| domain | Zinc finger C2H2-type | 455 - 485 | IPR013087 |
| conserved_site | Zinc finger, PHD-type, conserved site | 658 - 700 | IPR019786 |
| domain | PHD finger protein 20, AT hook | 176 - 280 | IPR022255 |
| domain | DNA repair protein Crb2, Tudor domain | 90 - 136 | IPR041297 |
6 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| histone acetyltransferase complex | A protein complex that possesses histone acetyltransferase activity. |
| MLL1 complex | A protein complex that can methylate lysine-4 of histone H3. MLL1/MLL is the catalytic methyltransferase subunit, and the complex also contains the core components ASH2L, HCFC1/HCF1 WDR5 and RBBP5. |
| NSL complex | A histone acetyltransferase complex that catalyzes the acetylation of a histone H4 lysine residues at several positions. In human, it contains the catalytic subunit MOF, NSL1/KIAA1267, NSL2/KANSL2, NSL3/KANSL3, MCRS1, PHF20, OGT1, WDR5 and HCF1. |
| nuclear membrane | Either of the lipid bilayers that surround the nucleus and form the nuclear envelope; excludes the intermembrane space. |
| nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
2 GO annotations of molecular function
| Name | Definition |
|---|---|
| DNA binding | Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). |
| metal ion binding | Binding to a metal ion. |
9 GO annotations of biological process
| Name | Definition |
|---|---|
| chromatin organization | The assembly or remodeling of chromatin composed of DNA complexed with histones, other associated proteins, and sometimes RNA. |
| histone acetylation | The modification of a histone by the addition of an acetyl group. |
| histone H4-K16 acetylation | The modification of histone H4 by the addition of an acetyl group to a lysine residue at position 16 of the histone. |
| histone H4-K5 acetylation | The modification of histone H4 by the addition of an acetyl group to a lysine residue at position 5 of the histone. |
| histone H4-K8 acetylation | The modification of histone H4 by the addition of an acetyl group to a lysine residue at position 8 of the histone. |
| positive regulation of DNA-templated transcription | Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. |
| positive regulation of histone H3-K4 methylation | Any process that activates or increases the frequency, rate or extent of the covalent addition of a methyl group to the lysine at position 4 of histone H3. |
| regulation of dosage compensation by inactivation of X chromosome | Any process that modulates the frequency, rate or extent of dosage compensation, by inactivation of X chromosome. |
| regulation of transcription by RNA polymerase II | Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MTKHPPNRRG | ISFEVGAQLE | ARDRLKNWYP | AHIEDIDYEE | GRVLIHFKRW | NHRYDEWFCW |
| 70 | 80 | 90 | 100 | 110 | 120 |
| DSPYLRPLEK | IQLRKEGLHD | EDGSSEFQIN | QQVLACWSDC | RFYPARVTAV | NKDGTYTVKF |
| 130 | 140 | 150 | 160 | 170 | 180 |
| YDGVVQTVKH | IHVKAFSKDQ | NIVGNARPKE | TDHKSLSSSP | EKREKFKEQR | KVTVNVKKDK |
| 190 | 200 | 210 | 220 | 230 | 240 |
| VEKALKTEKR | PKQPDKEGKL | ICSEKGKVSE | KSLPKNEKED | KENISENERE | YSGDAQVEKK |
| 250 | 260 | 270 | 280 | 290 | 300 |
| PEKDLVKNPQ | ENLKEPKRKR | GRPPSITPTA | VDSNSQTLQP | ITLELRRRKI | SKRSDTPLKR |
| 310 | 320 | 330 | 340 | 350 | 360 |
| PRLDKNSPQE | QSKKRSENSD | KDLSRRRSSR | LSTNGTREIL | DPDSIVPDLV | HTVDTNPLPD |
| 370 | 380 | 390 | 400 | 410 | 420 |
| KSPSAKDSAE | GQLKSPLEAG | QVSSALTCHP | IGDGLGAADL | ELNCKSMGEN | TMKTEPVSPL |
| 430 | 440 | 450 | 460 | 470 | 480 |
| AEVQEVSTVE | VPNTLKKVDD | SVTLNVPAVD | LDHKFRCKVL | DCLKFFRKAK | LLHYHMKYFH |
| 490 | 500 | 510 | 520 | 530 | 540 |
| GMEKSPEPEE | GPGKTHVQTR | GSAVPDKTSQ | ESLTRKRVSA | SSPTAKEKEK | TKEKKFKELV |
| 550 | 560 | 570 | 580 | 590 | 600 |
| RVKPKKKKKK | KKKTKPECPC | SEDISDTSQE | PSPPKTFAVT | RCGSSHKPGV | HMSPQLHGSD |
| 610 | 620 | 630 | 640 | 650 | 660 |
| NGNHKGKLKT | CEEDNLSESS | SESFLWSDEE | YGQDVDVTTN | PDEELEGDDR | YDFEVVRCIC |
| 670 | 680 | 690 | 700 | 710 | 720 |
| EVQEENDFMI | QCEECQCWQH | GVCMGLLEEN | VPEKYTCYVC | QDPPGQRPGF | KYWYDKEWLS |
| 730 | 740 | 750 | 760 | 770 | 780 |
| RGHMHGLAFL | DQNYSHQNAR | KIVATHQLLG | DVQRVIQVLH | GLQLKMSILQ | SREHPDLQLW |
| 790 | 800 | 810 | 820 | 830 | 840 |
| CQPWKQHSGE | GRAHPRHIHI | TDARSEESPS | YRTLNGAVEK | PSPLPRSVEE | SYITSEHCYQ |
| 850 | 860 | 870 | 880 | 890 | 900 |
| KPRAYYPAVE | QRLVVETRGS | ALDAAVSPLC | ENGDDSLSPR | LGWPIDQDRS | RGDIDPKPSS |
| 910 | 920 | 930 | 940 | 950 | 960 |
| PKVREYISKN | VLPEETPARK | LLDRGGEGLV | SSQHQWQFNL | LTHVESLQDE | VTHRMDSIEK |
| 970 | 980 | 990 | 1000 | ||
| ELDVLESWLD | YTGELEPPEP | LARLPQLKHC | IKQLLTDLGK | VQQIALCCST |